We are live on ! Find out more
INSY

Insys Therapeutics, Inc.
INSY

Delisted

INSY was delisted on the 18th of June, 2019.

Back to rankings

113 hedge funds and large institutions have $42.5M invested in Insys Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

3% more funds holding

Funds holding: 110 → 113 (+3)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

54% less call options, than puts

Call options by funds: $253K | Put options by funds: $551K

69% less capital invested

Capital invested by funds: $136M → $42.5M (-$93M)

Holders
113
Holders Change
+3
Holders Change %
+2.73%
% of All Funds
2.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
22
Reduced
24
Closed
22
Calls
$253K
Puts
$551K
Net Calls
-$298K
Net Calls Change
-$1.1M

Top Buyers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
+$10.2M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.18M
3
RCM
Raging Capital Management
New Jersey
+$1.98M
4
Millennium Management
Millennium Management
New York
+$1.78M
5
JC
JBF Capital
Colorado
+$695K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$30.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$3.82M
3
Deutsche Bank
Deutsche Bank
Germany
-$652K
4
BFM
Boothbay Fund Management
New York
-$621K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$591K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$202K -$73.7K -10,600 -16%
TA
27
Teachers Advisors
New York
$195K – – –
TCIM
28
TIAA CREF Investment Management
New York
$181K -$8.24K -1,186 -2%
JG
29
Jefferies Group
New York
$166K +$143K +20,612 +77%
Two Sigma Investments
30
Two Sigma Investments
New York
$156K +$311K +44,700 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$148K +$7.96K +1,145 +3%
Swiss National Bank
32
Swiss National Bank
Switzerland
$141K – – –
Invesco
33
Invesco
Georgia
$135K +$34K +4,892 +14%
CSS
34
Cubist Systematic Strategies
Connecticut
$134K +$267K +38,392 New
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$129K +$81K +11,657 +46%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$127K +$253K +36,347 New
WMSA
37
Weiss Multi-Strategy Advisers
New York
$123K – – –
BCM
38
Bridgeway Capital Management
Texas
$118K -$354K -50,900 -60%
Bank of America
39
Bank of America
North Carolina
$112K +$44.9K +6,462 +25%
ECM
40
Element Capital Management
New York
$99K +$196K +28,256 New
ProShare Advisors
41
ProShare Advisors
Maryland
$98K -$38.6K -5,558 -17%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$97K +$61.2K +8,800 +46%
Deutsche Bank
43
Deutsche Bank
Germany
$96K -$652K -93,763 -77%
UBS Group
44
UBS Group
Switzerland
$93K +$7.18K +1,033 +4%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$88K +$176K +25,263 New
AQR Capital Management
46
AQR Capital Management
Connecticut
$83K +$165K +23,680 New
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$81K -$38.2K -5,500 -19%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$79K – – –
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$63K – – –
AIG
50
American International Group
New York
$62K -$945 -136 -0.8%
1
2
3 4 5

INSY Hedge Fund Activity: Q4 2018 in Review

113 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Insys Therapeutics, Inc. (INSY) for Q4 2018, worth a combined $42.5M — down 69% from $136M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new INSY positions and 22 closed out — a net gain of 4 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was ETF Managers Group, opening a new position worth an estimated $10.2M. The largest seller was OrbiMed, exiting entirely with an estimated $30.5M sold.

  • 113 institutional investors held Insys Therapeutics, Inc. (INSY) as of Q4 2018, up from 110 in Q3 2018.
  • Funds reported $42.5M of Insys Therapeutics, Inc. stock for Q4 2018, down 69% quarter-over-quarter.
  • 26 funds opened new Insys Therapeutics, Inc. positions in Q4 2018 and 22 closed out, a net change of +4 holders.
  • The largest Insys Therapeutics, Inc. buyer in Q4 2018 was ETF Managers Group, an estimated $10.2M added.
  • The largest Insys Therapeutics, Inc. seller in Q4 2018 was OrbiMed, an estimated $30.5M sold.

Based on aggregated 13F filings for Q4 2018.